drugset / Trial / NCT04756661

Uterotonics for Severe Preeclampsia

NCT04756661

Completed 124 enrolled Assiut University
RandomizedParallel-groupOpen-labelPrevention

Summary

The study compares the effect of Intravenous carbetocin versus combined use of intravenous oxytocin and rectal misoprostol for prevention of postpartum hemorrhage during delivery of women with severe preeclampsia

Timeline

Start
2020-01-01
Primary completion
2020-12-31
Completion
2021-02-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Carbetocin Peptide 100 ug Intravenous
Comparator Misoprostol Other / unclassified 400 ug Rectal
Comparator Oxytocin Peptide 10 iu Intravenous

Indications